Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06726343 · ClinicalTrials.gov registry record · NA

Maternal Fetal Device Performance Singleton

A NA study, sponsored by GE Healthcare.

Completed
Registry status
NA
Development phase
30
Enrollment target

NCT06726343 is a NA study that has completed, run by GE Healthcare. The registered enrollment target is 30 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06726343, a NA study, has completed, sponsored by GE Healthcare.

COMPLETED
Registry status
NA
Development phase
30 participants
Enrollment target

Study Summary

Maternal Fetal Monitoring devices assist the health care professional in acquiring, monitoring, and storing fetal and maternal physiologic data which supports the decision making for pregnant women and the overall fetal health status during pregnancy and delivery. This study aims to support a new maternal fetal monitoring device with clinical data to demonstrate the equivalent performance against the currently marketed Corometrics 259cx. The fetal heart rate and will be collected during antenatal monitoring using standard of care Doppler ultrasound.

Interventions

  • DEVICE Fetal Monitoring Device
  • DEVICE Investigational Fetal Monitoring Device

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2024-10-28
Est. Completion 2024-12-23
Phase NA

Sponsor

GE Healthcare

99 total trials

What the Registry Record Tells You About NCT06726343

The ClinicalTrials.gov registry entry for NCT06726343 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is GE Healthcare, which has 99 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Fetal Monitoring Device is the first listed.

NCT06726343 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT06726343 about?

NCT06726343 is a clinical study titled "Maternal Fetal Device Performance Singleton". Maternal Fetal Monitoring devices assist the health care professional in acquiring, monitoring, and storing fetal and maternal physiologic data which supports the decision making for pregnant women and the overall fetal health status during pregnancy and delivery. This study aims to support a new ma...

What is the current status of trial NCT06726343?

This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2024-10-28. Estimated completion is 2024-12-23.

What interventions are being tested in trial NCT06726343?

The interventions under investigation include: Fetal Monitoring Device (DEVICE), Investigational Fetal Monitoring Device (DEVICE).

Who is sponsoring clinical trial NCT06726343?

This trial is sponsored by GE Healthcare, which has 99 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.